{
    "ticker": "GBIO",
    "name": "Generation Bio Co.",
    "description": "Generation Bio Co. is a biotechnology company that specializes in developing gene therapies for genetic diseases. Founded in 2016, the company is focused on harnessing the power of its proprietary gene therapy platform to create transformative treatments for patients with rare and prevalent diseases. Generation Bio's innovative approach utilizes a non-viral delivery system to enable precise and sustained gene expression, which aims to overcome limitations associated with traditional gene therapy methods. The company is actively advancing its lead product candidates through clinical development, targeting conditions such as hemophilia and other inherited disorders. Generation Bio's mission is to provide long-lasting and safe therapeutic solutions that can significantly improve the quality of life for individuals affected by genetic diseases. With a robust pipeline and a dedicated team of scientists and industry experts, Generation Bio is positioned to be a leader in the next generation of gene therapies.",
    "industry": [
        "Biotechnology",
        "Pharmaceuticals"
    ],
    "headquarters": "Cambridge, Massachusetts, USA",
    "founded": "2016",
    "website": "https://www.generationbio.com",
    "ceo": "Geoffrey A. M. Hsu",
    "social_media": {
        "twitter": "https://twitter.com/GenerationBio",
        "linkedin": "https://www.linkedin.com/company/generation-bio/"
    },
    "investor_relations": "https://investors.generationbio.com",
    "key_executives": [
        {
            "name": "Geoffrey A. M. Hsu",
            "position": "CEO"
        },
        {
            "name": "Ellen M. B. E. H. B. Hsu",
            "position": "CFO"
        }
    ],
    "product_categories": [
        {
            "category": "Gene Therapies",
            "products": [
                "GB-401",
                "GB-402"
            ]
        }
    ],
    "seo": {
        "meta_title": "Generation Bio Co. | Innovating Gene Therapies",
        "meta_description": "Explore Generation Bio Co., a biotechnology company focused on developing innovative gene therapies for genetic diseases. Learn about our mission and pipelines.",
        "keywords": [
            "Generation Bio",
            "Gene Therapy",
            "Biotechnology",
            "Genetic Diseases",
            "Hemophilia",
            "GB-401",
            "GB-402"
        ]
    },
    "faq": [
        {
            "question": "What does Generation Bio specialize in?",
            "answer": "Generation Bio specializes in developing gene therapies for genetic diseases using a proprietary non-viral delivery system."
        },
        {
            "question": "Who is the CEO of Generation Bio?",
            "answer": "Geoffrey A. M. Hsu is the CEO of Generation Bio Co."
        },
        {
            "question": "Where is Generation Bio headquartered?",
            "answer": "Generation Bio is headquartered in Cambridge, Massachusetts, USA."
        },
        {
            "question": "What are Generation Bio's main products?",
            "answer": "Generation Bio's main product candidates include GB-401 and GB-402, targeting hemophilia and other genetic conditions."
        },
        {
            "question": "When was Generation Bio founded?",
            "answer": "Generation Bio was founded in 2016."
        }
    ],
    "competitors": [
        "EDIT",
        "CRSP",
        "SGMO",
        "BMRN"
    ],
    "related_stocks": [
        "AMGN",
        "GILD",
        "VRTX",
        "REGN"
    ]
}